**Tester Agent – Feature Evaluation Report**

**1. Baseline Predictive Performance (all 69 features)**  
| Metric | Value |
|--------|-------|
| AUC (ROC‑AUC) | **0.768** |
| Accuracy | **0.987** |
| Confusion Matrix (0.5 threshold) | [[818 TN, 1 FP], [10 FN, 0 TP]] |
| Positive‑class Recall | **0 %** (the model never predicts the minority ‘survival’ class) |
| Positive‑class Precision | **0 %** |

*Interpretation*: The model separates the two classes reasonably (AUC ≈ 0.77) but, because the positive class is extremely rare (≈ 1 % of the data), a 0.5 decision threshold yields no true positives. The high accuracy is therefore driven by the dominant negative class.

**2. Feature Importance (XGBoost gain)**  
Top 15 features that contributed most to the model’s split‑gain (ordered by importance):

1. **antibiotic_std_dose_x_antibiotic_duration**  
2. **unit_eq_test**  
3. **antibiotic_glycopeptide_total_dose**  
4. **antibiotic_duration_x_sedation_total**  
5. **antibiotic_last_time_min**  
6. **drug_class_switch_norepi_to_vasopressin_count**  
7. **antibiotic_total_std_dose_ug**  
8. **vasopressin_total_dose_after_first**  
9. **test_vaso_cond**  
10. **antibiotic_admin_count**  
11. **dose_sum_by_id**  
12. **antibiotic_therapy_duration_min**  
13. **interaction_unit_abx**  
14. **antibiotic_glycopeptide_dose_rate_per_hour**  
15. **interaction_vaso_abx**

These attributes are largely related to **antibiotic exposure**, **vasopressor usage**, and **drug‑class switching**, suggesting they capture important aspects of intensive‑care pharmacotherapy that differentiate survivors with high EEG suppression ratios.

**3. Redundancy & Correlation Analysis**  
Pairwise absolute Pearson correlations (> 0.9) revealed several near‑perfect duplicates:

| Feature A | Feature B | |r| |
|-----------|-----------|------|
| `dose_sum_by_id` | `dose_sum` | **1.0** |
| `dose_sum_by_id` | `test_total_dose` | **1.0** |
| `sedation_total_dose` | `sedation_max_dose` | **0.999996** |
| `sedation_total_dose` | `antibiotic_duration_x_sedation_total` | **0.999914** |
| `sedation_total_dose` | `sedation_total_std_dose_ug` | **0.989652** |
| `fluid_total_volume` | `fluid_total_mL_volume` | **0.982690** |
| `fluid_total_volume` | `fluid_crystalloid_volume` | **0.996911** |
| `antibiotic_therapy_duration_min` | `antibiotic_last_time_min` | **0.995267** |
| `antibiotic_therapy_duration_min` | `antibiotic_duration_x_norepi_total` | **1.00** |
| `test_attr` | `unit_test` | **1.0** |
| `test_bracket` | `test_dummy_mean_dose` | **1.0** |
| `test_bracket` | `test_dummy_mean_dose2` | **1.0** |

These redundancies inflate the feature set without adding new information.

**4. Feature Pruning Experiment**  
We removed 17 highly‑correlated / duplicate attributes (e.g., `dose_sum`, `test_total_dose`, `sedation_max_dose`, fluid volume variants, duplicate antibiotic timing metrics, etc.).

*Result after pruning (53 remaining features)*  

| Metric | Value |
|--------|-------|
| AUC | **0.730** (↓ 0.04) |
| Accuracy | **0.987** (unchanged) |
| Positive‑class Recall | **0 %** (unchanged) |
| Positive‑class Precision | **0 %** (unchanged) |

The drop in AUC indicates that some of the eliminated duplicates carried marginal predictive signal (likely because the model could exploit subtle numeric differences). However, the inability to predict any survivors persists, confirming that the current feature set (even after pruning) does not provide a discriminative threshold for the minority class under the default 0.5 cut‑off.

**5. Key Observations & Take‑aways**

* **Predictive Power** – The aggregated features achieve moderate discrimination (AUC ≈ 0.77) but fail to identify individual surviving patients when using a naïve threshold. This is a classic class‑imbalance issue; alternative thresholds, re‑sampling, or cost‑sensitive learning would be required for practical detection, but such model‑level adjustments are outside the current evaluation scope.
* **Most Informative Domains** – Antibiotic‑related composite metrics and vasopressor‑related interaction terms dominate importance rankings, hinting that **intensive pharmacologic management** (dose intensity, timing, and drug‑class switches) may be the key drivers of survival despite high EEG suppression.
* **Redundancy** – The dataset contains many perfectly collinear columns (e.g., multiple copies of total dose). Pruning these reduces dimensionality with only a modest AUC penalty, simplifying downstream modeling and interpretation.
* **Robustness** – Adding or removing the duplicated columns does not alter the fundamental limitation (zero recall). Hence, the lack of positive predictions is not due to noisy or irrelevant features but rather to the extreme class imbalance and possibly insufficient signal in the current attribute set.

**6. Recommendations for the Scientist & Extractor Agents (informational only)**  

* **Focus Extraction** on the high‑importance antibiotic and vasopressor interaction attributes (e.g., `antibiotic_std_dose_x_antibiotic_duration`, `vasopressin_total_dose_after_first`, `drug_class_switch_norepi_to_vasopressin_count`).  
* **Consider Deriving** additional features that capture *relative* exposure (e.g., ratios, time‑normalized doses) or *temporal patterns* that may better separate survivors.  
* **Address Class Imbalance** in subsequent modeling (e.g., oversampling survivors, using calibrated probability thresholds) to translate the modest AUC into usable predictions.  

*All findings above are based on the provided feature set, using standard XGBoost classification and SHAP‑style gain importance. No additional feature engineering or model‑tuning beyond the described experiments was performed.*